The estimated Net Worth of Dana Yaacov Garbeli is at least $101 mil dollars as of 11 November 2022. Ms. Garbeli owns over 56,580 units of Entera Bio Ltd stock worth over $100,712 and over the last 2 years she sold ENTX stock worth over $0. In addition, she makes $0 as Chief Financial Officer at Entera Bio Ltd.
Sign up
Ms. Garbeli ENTX stock SEC Form 4 insiders trading
Dana has made over 1 trades of the Entera Bio Ltd stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 56,580 units of ENTX stock worth $29,987 on 11 November 2022.
The largest trade she's ever made was buying 56,580 units of Entera Bio Ltd stock on 11 November 2022 worth over $29,987. On average, Dana trades about 14,145 units every 0 days since 2022. As of 11 November 2022 she still owns at least 56,580 units of Entera Bio Ltd stock.
You can see the complete history of Ms. Garbeli stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dana Yaacov-Garbeli biography
Dana Yaacov-Garbeli CPA serves as Chief Financial Officer of the Company. Ms. Yaacov-Garbeli is currently a partner at A2Z Finance Ltd, where she serves as an outsourced CFO to both private and publicly traded companies and provides additional consulting and accounting services. Ms. Yaacov-Garbeli previously served at PricewaterhouseCoopers Israel, including a short secondment to PricewaterhouseCoopers New York as a Senior Manager on audits of both public and privately held multi-national companies based in Israel, US and Europe, mainly in the pharmaceutical and biotech sectors. Ms. Yaacov-Garbeli holds a B.A in accounting and business management and an MBA in financial management from The College of Management and Academic studies. Ms. Yaacov-Garbeli is a Certified Public Accountant in Israel.
How old is Dana Garbeli?
Dana Garbeli is 36, she's been the Chief Financial Officer of Entera Bio Ltd since 2019. There are 18 older and no younger executives at Entera Bio Ltd. The oldest executive at Entera Bio Ltd is Gerald Lieberman, 73, who is the Independent Chairman of the Board.
What's Dana Garbeli's mailing address?
Dana's mailing address filed with the SEC is KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, L3, 9112002.
Insiders trading at Entera Bio Ltd
Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, eSean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.
What does Entera Bio Ltd's logo look like?
Complete history of Ms. Garbeli stock trades at Entera Bio Ltd
Entera Bio Ltd executives and stock owners
Entera Bio Ltd executives and other stock owners filed with the SEC include:
-
Phillip Schwartz,
President of Research and Development -
Gerald Lieberman,
Independent Chairman of the Board -
Arthur Santora,
Chief Medical Officer -
Dr. Phillip Schwartz Ph.D.,
Exec. VP, Pres of R&D and Director -
Roger Garceau,
Chief Executive Officer, Director -
Hillel Galitzer,
Chief Operating Officer -
Dr. Hillel Galitzer,
Chief Operating Officer -
Dr. Arthur C. Santora II, M.D., Ph.D.,
Chief Medical Officer -
Kiryat Hadassah,
IR Contact Officer -
Miranda Toledano,
Independent Director -
Gerald Ostrov,
Independent Director -
Faith Charles,
Independent Director -
Yonatan Malca,
Director -
Sean Ellis,
Director -
Zeev Bronfeld,
Director -
Jonathan Lieber,
Chief Financial Officer - U.S.-based -
Dana Yaacov-Garbeli,
Chief Financial Officer -
Dr. Roger J. Garceau,
Chief Devel. Advisor & Director -
Ramesh Ratan,
U.S. Chief Financial Officer -
Dana Yaacov-Garbeli CPA,
Chief Financial Officer -
Dr. Spiros Jamas,
CEO & Director -
Haya Taitel,
Director -
Ramesh Ratan,
U.S.based CFO -
Spiros Jamas,
Chief Executive Officer -
Ron Mayron,
Director